Articles Archives - Page 166 of 715

MondayApr 17, 2023 10:30 am

Cartier Silver Corp. (CSE: CFE) Follows in Eloro Resources Ltd.’s (TSX: ELO) (OTCQX: ELRRF) Footsteps Within Bolivia’s Potosi Region

Cartier Iron opted to change its name to Cartier Silver in October 2022, part of a wider pivot within its business plan The revamped company, which is both a sister company and minority shareholder in Eloro Resources (TSX: ELO), recently optioned 100% of the zinc-silver Los Chorrillos Project, within Bolivia’s Cerro Rico region The company, which boasts the same, experienced management team as Eloro Resources’, recently completed their initial capital raise of $3 million Proceeds from the capital raise will be used to finance initial exploration at the Los Chorillos site In October 2022, when Cartier Iron made a dramatic…

MondayApr 17, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes the Licensed Use of its DehydraTECH(TM) Technology to Complement its Royalty Earnings and Realize Revenue in Advance of Royalties

Chris Bunka, Lexaria’s CEO, has reiterated the company’s commitment to creating value for its shareholders with the licensed use of its patented DehydraTECH(TM) technology Mr. Bunka has noted that Lexaria is already in discussions with interested parties in Europe and North America, a move that presents a critical fiscal opportunity for the company He has emphasized how profitable new licensing agreements could be for the company, presenting additional avenues for Lexaria to generate revenue and create value for its shareholders As the company continues to make a transition toward a more commercial focus in 2023, Bunka notes that licensing will…

MondayApr 17, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Scale its Maximum Production Rate to 7,500 TPA Following the Selection of LSMC REE Separation and Oxide Production Facility

Ucore just announced the selection of an 80,800 square-foot brownfield facility located in England Airpark in Alexandria, Louisiana, that will serve as the company’s LSMC REE separation and oxide production facility The company is confident that the establishment will expand its maximum production rate from the current 5,000 TPA to 7,500 TPA in TREO throughout by 2027 The facility is expected to create 298 indirect jobs, for a total of 398 new jobs in Central Louisiana. It is also set to bring the total potential value of state grants, tax incentives, 1payroll rebates, and other benefits to US$15 million Ucore…

FridayApr 14, 2023 11:15 am

SideChannel Inc. (SDCH) CEO Brian Haugli Discusses Government TikTok Ban in Forum Daily Interview

Governments worldwide are pushing for the ban of TikTok from government devices, citing threats to national security Chinese company ByteDance, the owner and creator of TikTok, believes the ban is premature and has not had the opportunity to answer questions relating to information security Haugli explains that default permissions, including location, contacts, media, and more, are required at the time of download – making it possible for ByteDance to store data and metadata that could pose a risk Deteriorating relationships between China and other world governments have raised concerns about how much data is shared on popular social media apps…

FridayApr 14, 2023 10:30 am

DGE’s 3rd KOL Engagement Forum: Learn and Network with Leaders in the Medical Affairs and MSL Community

In a time of unprecedented public fear and distrust of institutions, life science companies must be more careful than ever to cultivate KOL (Key Opinion Leader) relationships that lend credibility to their products. As regulations grow stricter, and demand for niche products and personalized treatment rises, KOLs are set to play an even more important role in winning acceptance among the medical community. The increasing trend toward personalized healthcare research online and via other forms of media has created a greater need for medical product developers to competitively market their messages across a wide spectrum of media audiences and prioritize…

FridayApr 14, 2023 9:45 am

Lidar Pioneer Cepton, Inc. (NASDAQ: CPTN) Bridges Technological Gaps to Advance Mass Market ADAS Adoption

Cepton unveiled its Vista(R)-X120 Plus earlier this year at CES 2023, one of the largest tech tradeshows this year, where it was named a CES 2023 innovation award honoree for next-generation lidar products Vista(R)-X120 Plus features a wider field of view, software-definable regions of interest, and faster data transmission with a target price below $500, enabling high-volume production and faster mass-market adoption Vista(R)-X120 Plus is smaller and lighter, allowing for seamless integration without significantly affecting vehicle design Cepton collaborates with many global OEMS, and recently won the largest commercial lidar deployment contract in the tolling sector to date Advanced Driver…

FridayApr 14, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Discusses Positive Results from In Vivo Proof-of-Concept Study of Its Anti-COVID-19 NanoAb Therapy and Additional Pipeline Plans at BIO-Europe Spring

BiondVax Pharmaceuticals is a biotechnology company developing, manufacturing, and commercializing innovative NanoAb immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases Company CEO Amir Reichman recently presented at the BIO-Europe Spring conference, where he talked about BiondVax’s successful preclinical in vivo results of its innovative inhaled COVID-19 treatment and additional pipeline plans The in vivo results have shown that the company’s inhaled COVID-19 therapy, formulated using alpaca-derived nanosized antibodies (“NanoAbs”), resulted in milder and shorter illness, virtually eliminated the virus from the lungs, and prophylactically protected against illness Since he was appointed CEO in early 2021, Reichman…

ThursdayApr 13, 2023 10:30 am

DGE’s 7th Digital Strategy & Innovation for Medical Affairs Summit to Focus on the Cultural Digital Revolution For Medical Affairs Teams

DGE invites industry executives, policymakers, and health providers, to attend the 7th Digital Strategy & Innovation for Medical Affairs Summit to be held in Philadelphia from May 17-18, 2023, in addition to being live streamed. The 7th Digital Strategy & Innovation for Medical Affairs Summit is the leading and most influential industry conference for transforming the MA department into a division that executes advanced policies and patient centricity. In a world where business models and medical science are increasingly complicated and data-driven, MA teams have emerged as the key players not only in ensuring the success of their companies but…

ThursdayApr 13, 2023 9:45 am

Coyuchi Inc. Recently-Opened Palo Alto Store Helps Bring To Life The Coyuchi Luxury Experience

Marcus Chung, the brand’s first COO, who is leading the company’s growth strategy, played an integral role in the opening of the Palo Alto store Coyuchi is pushing the organic textile market forward through its circular business model, the creation of The Coyuchi Climate Council, and the foundation of C4: The California Cotton & Climate Coalition Regulation A+ funding is being used to expand Coyuchi’s enterprise value through expanded marketing, product category expansion, and its physical store presence that brings a direct-to-consumer experience to life, along with B2B strategic partnerships with wholesalers and online marketplaces Coyuchi, the gold standard in…

ThursdayApr 13, 2023 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Global Trial Targets Unmet Medical Need in Arresting GBM Brain Cancer

Glioblastoma (“GBM”), an aggressive and generally fatal brain cancer, has attracted attention as a significant unmet medical need because of its incurability, claiming the lives of more than 200,000 patients worldwide each year CNS Pharmaceuticals is in the middle of a potentially pivotal global Phase 2 clinical trial for its drug candidate, a novel anthracycline called Berubicin that is apparently unique in its ability to cross the blood-brain barrier to target central nervous system tumors CNS’s clinical trial sites have begun enrolling patients in the United States, France, Spain and Switzerland, with sites prepared to receive patients in Italy as…

Site Search

Company Search

Category: Articles